Yıl: 2011 Cilt: 22 Sayı: 6 Sayfa Aralığı: 602 - 605 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Intrahepatic cholestasis of pregnancy: Correlation of preterm delivery with bile acids

Öz:
Amaç: Bu çalışmada, gebelikte gözlenen intrahepatik kolestaz olgularının insidansı, obstetrik ve fetal komplikasyonlarının tanımlanması ve ortaya konulan sonuçların karaciğer fonksiyon testleri ve safra asitleri ile korelasyonunun değerlendirilmesi amaçlandı. Yöntem: Kliniğimizde antenatal takibi yapılan ve doğumu gerçekleştirilen 3710 olgunun 32’sinde gebeliğin intrahepatik kolestazı tanısı konuldu. Olguların obstetrik-medikal hikâyeleri, laboratuvar sonuçları, belirtilerin başlama tarihi, kaşıntı dereceleri, tedaviye cevapları, doğum zamanlamaları, yenidoğan bebeklerin bilgileri çalışma protokolüne alındı. ‹statistiki analizler SPSS 12.0 versiyon kullanılarak yapıldı. Korelasyonun ortaya konulmasında Spearman Rank Korelasyon Analizi kullanıldı. Bulgular: ‹ntrahepatik kolestaz olgularının insidansı %0.86 olarak bulundu. Semptomlar 32. hafta civarında gözlendi. Multipar olguların %16,6’sında daha önceki gebelikte, gebeliğin intrahepatik kolestazının gözlendiği, tüm olguların ise %21,8’inde aile öyküsünün olduğ u saptandı. Semptomların gözlenme zamanının mevsimlere göre değiştiği ve bunun istatistiki olarak anlamlı olduğu gözlendi (p<0.05). Olgularının büyük çoğunluğunun (%69.5) kış aylarında veya ilkbahar başlarında gözlendiği ortaya konuldu. Hiçbir olguda klinik olarak sarılık, kanamaya meyil veya fetal ölüm gözlenmedi. Ursadeoksikolik asit ile kaşıntı şiddeti azaldı. Erken do- ğum gözlenen olgularda ise serum safra asitlerinin daha yüksek olduğu ortaya konuldu (r=0.409, p=0.038). Sonuç: Total safra asitleri erken doğum ile koreledir. 38. haftalarda doğum planlaması ile perinatal outcome iyileştirilebilir.
Anahtar Kelime:

Konular: Cerrahi

Gebeliğin intrahepatik kolestazı: Safra asitleri ile preterm doğumun korelasyonu

Öz:
Background/aims: The aim of this study was to determine the incidence, obstetrical and fetal complication rates of intrahepatic cholestasis of pregnancy in patients managed actively around 38 weeks and evaluate the correlation of these results with liver function tests and bile acids. Material and Methods: In this cohort study 3710 women were booked for delivery, of which 32 pregnant women were diagnosed as intrahepatic cholestasis of pregnancy. All data concerning obstetric- medical history, laboratory results, symptom onset time, pruritus degree, treatment response, and delivery time and infants information were recorded in the study protocol. Statistical analyses were conducted with SPSS 12.0 version and correlations were assessed by Spearman Rank correlation analysis. Results: The incidence of intrahepatic cholestasis of pregnancy was 0.86%. The symptoms appeared around 32 weeks. 16.6% multiparas had a previously affected pregnancy and 21.8% of intrahepatic cholestasis of pregnancy patients had family history of intrahepatic cholestasis of pregnancy. Symptom onset varied according to season (p<0.05). Most patients (69.5%) were diagnosed in winter and the beginning of spring. There were no reported cases of clinical maternal jaundice, bleeding tendency or stillbirth. Pruritus was decreased by ursodeoxycholic acid treatment. Total bile acids tended to be higher in patients with preterm delivery (r=0.409, p=0.038). Conclusion: Total bile acids are correlated with preterm delivery. An attempt to deliver at around 38 weeks may improve perinatal outcome.
Anahtar Kelime:

Konular: Cerrahi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Pathak B, Sheibani L, Lee RH. Cholestasis of pregnancy. Obstet Gynecol Clin North Am 2010; 37: 269-82.
  • 2. Nichols AA. Cholestasis of pregnancy: a review of the evidence. J Perinat Neonatal Nurs 2005; 19: 217-25.
  • 3. Jamjute P, Ahmad A, Ghosh T, Banfield P. Liver function test and pregnancy. J Matern Fetal Neonatal Med 2009; 22: 274-83.
  • 4. Savander M, Ropponen A, Avela K, et al. Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy. Gut 2003; 52: 1025-9.
  • 5. Incerpi M, Hethamuni R, Goodwin M. Serum bile acids as an indicator of intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol 2001; 184: 189.
  • 6. Schutt VA, Minuk GY. Liver diseases unique to pregnancy. Best Pract Res Clin Gastroenterol 2007; 21: 771-92.
  • 7. Lee RH, Incerpi MH, Miller DA. Sudden fetal death in intrahepatic cholestasis of pregnancy. Obstet Gynecol 2009; 113: 528-31.
  • 8. Brites D. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid. Ann Hepatol 2002; 1: 20-8.
  • 9. May JK. The active management of intrahepatic cholestasis of pregnancy. Curr Opin Obstet Gynecol 2010; 22: 100- 3.
  • 10. Kondrackiene J, Kupcinskas L. Current achievements and unsolved problems. World J Gastroenterol 2008; 14: 5781- 8.
  • 11. Kondrackiene J, Beuers U, Zalinkevicius R, et al. Predictors of premature delivery in patients with intrahepatic cholestasis of pregnancy. World J Gastroenterol 2007; 13: 6226-30.
  • 12. Lee RH, Kwok KM, Ingles S, et al. Pregnancy outcomes during an era of aggressive management for intrahepatic cholestasis of pregnancy. Am J Perinatol 2008; 25: 341-5.
  • 13. Al Shobaili HA, Hamed HO, Al Robaee A, et al. Obstetrical and fetal outcomes of a new management strategy in patients with intra-hepatic cholestasis of pregnancy. Arch Gynecol Obstet 2011; 283: 1219-25.
  • 14. Arrese M, Reyes H. Intrahepatic cholestasis of pregnancy: a past and present riddle. Ann Hepatol 2006; 5: 202-5. 15. Singh GCL, Sidhu MK. Cholestasis of pregnancy. MJAFI 2008; 63: 343-5.
  • 16. Reyes H, Simon FR. Intrahepatic cholestasis of pregnancy: an estrogen-related disease. Semin Liver Dis 1993; 13: 289-301.
  • 17. Bacq Y, Sapey T, Brechot MC, et al. Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology 1997; 26: 358-64.
  • 18. Alsulyman OM, Ouzounian JG, Ames-Castro M, Goodwin TM. Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. Am J Obstet Gynecol 1996; 175: 957-60.
  • 19. Heinonen S, Kirkinen P. Pregnancy outcome with intrahepatic cholestasis. Obstet Gynecol 1999; 94: 189-93.
  • 20. Palma J, Reyes H, Ribalta J, et al. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, doubleblind study controlled with placebo. J Hepatol 1997; 27: 1022-8.
  • 21. Mazzella G, Rizzo N, Azzaroli F, et al. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers. Hepatology 2001; 33: 504-8.
  • 22. Germain AM, Kato S, Carvajal JA, et al. Bile acids increase response and expression of human myometrial oxytocin receptor. Am J Obstet Gynecol 2003; 189: 577-82.
  • 23. Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 2004; 40: 467-74.
  • 24. Glantz A, Marschall HU, Lammert F, Mattsson LA. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 2005; 42: 1399-405.
APA PATA O, VARDARELİ E, ÖZCAN A, Serteser M, ÜNSAL İ, Saruç M, Ünlü M, Tozun A (2011). Intrahepatic cholestasis of pregnancy: Correlation of preterm delivery with bile acids. , 602 - 605.
Chicago PATA OZLEM,VARDARELİ Eser,ÖZCAN Alihan,Serteser Mustafa,ÜNSAL İbrahim,Saruç Murat,Ünlü Mehmet Cihat,Tozun Ayse Nurdan Intrahepatic cholestasis of pregnancy: Correlation of preterm delivery with bile acids. (2011): 602 - 605.
MLA PATA OZLEM,VARDARELİ Eser,ÖZCAN Alihan,Serteser Mustafa,ÜNSAL İbrahim,Saruç Murat,Ünlü Mehmet Cihat,Tozun Ayse Nurdan Intrahepatic cholestasis of pregnancy: Correlation of preterm delivery with bile acids. , 2011, ss.602 - 605.
AMA PATA O,VARDARELİ E,ÖZCAN A,Serteser M,ÜNSAL İ,Saruç M,Ünlü M,Tozun A Intrahepatic cholestasis of pregnancy: Correlation of preterm delivery with bile acids. . 2011; 602 - 605.
Vancouver PATA O,VARDARELİ E,ÖZCAN A,Serteser M,ÜNSAL İ,Saruç M,Ünlü M,Tozun A Intrahepatic cholestasis of pregnancy: Correlation of preterm delivery with bile acids. . 2011; 602 - 605.
IEEE PATA O,VARDARELİ E,ÖZCAN A,Serteser M,ÜNSAL İ,Saruç M,Ünlü M,Tozun A "Intrahepatic cholestasis of pregnancy: Correlation of preterm delivery with bile acids." , ss.602 - 605, 2011.
ISNAD PATA, OZLEM vd. "Intrahepatic cholestasis of pregnancy: Correlation of preterm delivery with bile acids". (2011), 602-605.
APA PATA O, VARDARELİ E, ÖZCAN A, Serteser M, ÜNSAL İ, Saruç M, Ünlü M, Tozun A (2011). Intrahepatic cholestasis of pregnancy: Correlation of preterm delivery with bile acids. Turkish Journal of Gastroenterology, 22(6), 602 - 605.
Chicago PATA OZLEM,VARDARELİ Eser,ÖZCAN Alihan,Serteser Mustafa,ÜNSAL İbrahim,Saruç Murat,Ünlü Mehmet Cihat,Tozun Ayse Nurdan Intrahepatic cholestasis of pregnancy: Correlation of preterm delivery with bile acids. Turkish Journal of Gastroenterology 22, no.6 (2011): 602 - 605.
MLA PATA OZLEM,VARDARELİ Eser,ÖZCAN Alihan,Serteser Mustafa,ÜNSAL İbrahim,Saruç Murat,Ünlü Mehmet Cihat,Tozun Ayse Nurdan Intrahepatic cholestasis of pregnancy: Correlation of preterm delivery with bile acids. Turkish Journal of Gastroenterology, vol.22, no.6, 2011, ss.602 - 605.
AMA PATA O,VARDARELİ E,ÖZCAN A,Serteser M,ÜNSAL İ,Saruç M,Ünlü M,Tozun A Intrahepatic cholestasis of pregnancy: Correlation of preterm delivery with bile acids. Turkish Journal of Gastroenterology. 2011; 22(6): 602 - 605.
Vancouver PATA O,VARDARELİ E,ÖZCAN A,Serteser M,ÜNSAL İ,Saruç M,Ünlü M,Tozun A Intrahepatic cholestasis of pregnancy: Correlation of preterm delivery with bile acids. Turkish Journal of Gastroenterology. 2011; 22(6): 602 - 605.
IEEE PATA O,VARDARELİ E,ÖZCAN A,Serteser M,ÜNSAL İ,Saruç M,Ünlü M,Tozun A "Intrahepatic cholestasis of pregnancy: Correlation of preterm delivery with bile acids." Turkish Journal of Gastroenterology, 22, ss.602 - 605, 2011.
ISNAD PATA, OZLEM vd. "Intrahepatic cholestasis of pregnancy: Correlation of preterm delivery with bile acids". Turkish Journal of Gastroenterology 22/6 (2011), 602-605.